Imidazole Derivative Synthesis via Ionic Liquid Catalysis

Resolve Bottlenecks,
Find Innovative Solutions
Generate Solutions

Solution Overview

Problem

There is a growing need for new antimicrobial agents effective against drug-resistant microorganisms, particularly bacteria and fungi, due to increasing resistance to conventional antibiotics, and existing methods for synthesizing organic compounds often involve hazardous solvents and inefficient processes.

Innovation Solution

The synthesis of 5-(4,5-bis(4-bromophenyl)-2-(4-chlorophenyl)-1H-imidazol-1-yl)pentanoic acid via a one-pot four-component reaction using pyridinium ionic liquid as a catalyst and solvent, which demonstrates excellent antimicrobial activity against various microbes, including gram-positive and gram-negative bacteria, and fungi.

Engineering Contradictions & Design Principles

VSEngineering Contradiction Analysis

1Reliability

If conventional antibiotics are used to treat bacterial infections, then treatment effectiveness is reduced, but antimicrobial resistance increases

Engineering Contradiction:
Improvetreatment effectivenessVSAvoidantimicrobial resistance
Core Design Contradiction:
ReliabilityVSObject-affected harmful factors

Solution Approach 1:

The patent modifies the chemical structure by introducing specific substituents (bromophenyl, chlorophenyl groups) at defined positions on the imidazole ring, changing the pharmacological parameters to achieve activity against drug-resistant microorganisms while maintaining therapeutic effectiveness

Inventive Principle:
Principle #35Parameter changes

Solution Approach 2:

The compound combines multiple pharmacophores (imidazole core, aromatic substituents, carboxylic acid side chain) into a single molecular entity that exhibits synergistic antimicrobial activity against both gram-positive and gram-negative bacteria, as well as fungi

Inventive Principle:
Principle #40Composite materials

2Productivity

If traditional synthesis methods are used for organic compounds, then product yield is achieved, but hazardous solvents and inefficient processes are employed

Engineering Contradiction:
Improveproduct yieldVSAvoidhazardous solvents
Core Design Contradiction:
ProductivityVSObject-generated harmful factors

Solution Approach 1:

The patent converts the traditionally harmful role of solvents into a beneficial catalytic function by using ionic liquids that serve both as reaction media and catalysts, eliminating the need for separate hazardous solvents while enhancing product yield and purity

Inventive Principle:
Principle #22Blessing in disguise (Convert harm into benefit)

Solution Approach 2:

The ionic liquid acts as an intermediary substance that facilitates the multi-component reaction between aldehyde, amine, and β-dicarbonyl compounds, enabling efficient imidazole formation while providing an environmentally friendly alternative to conventional solvents

Inventive Principle:
Principle #24Intermediary (Mediator)

Applied Scientific Principles

This section explains which scientific principles are used to turn an abstract innovation direction into a practical engineering solution.

Function Achieved in This Case

The compound exhibits significant antimicrobial activity against Bacillus cereus, Staphylococcus aureus, Pseudomonas aeruginosa, Escherichia coli, Aspergillus flavus, and Chrysosporium keratinophilum, offering a promising therapeutic option for microbial infections while employing a greener, more efficient synthesis method.

Implementation Method 1

Pyridinium ionic liquid as a catalyst and green solvent

Methodology Applied
Scientific EffectCatalysis: Catalysis

Implementation Method 2

chemical transformations performed under ultrasound irradiation

Methodology Applied
Scientific EffectUltrasonic vibration: Ultrasonic Vibration

Data Source

PatentUS11939298B15-(4,5-bis(4-bromophenyl)-2-(4-chlorophenyl)-1H-imidazol-1-yl)pentanoic acid as an antimicrobial compound
Publication Date: 2024.03.26 KING FAISAL UNIV
  • US11939298B1 patent drawing
  • US11939298B1 patent drawing
  • US11939298B1 patent drawing

AI summary

A 5-(4,5-bis(4-bromophenyl)-2-(4-chlorophenyl)-1H-imidazol-1-yl)pentanoic acid compound, its synthesis, and its use as an antimicrobial agent.